RxDoctor Payments Data
★ My doctorsLook up a doctor →

Ageliki Vouyouka, MD

Vascular Surgery · New York, NYNPI 1326081548

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $13,343 of the $14,888 with a category attached, or 89.6%. 22 manufacturers reported payments, led by Medtronic at 38.5% of the total. Reporting peaked in 2019 at $4,102 and has fallen 74.3% since, to $1,054 in 2025.

$14,888in general payments, 2019–2025

Across 196 payments — averaging $75.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$6K
  • Boston Scientific$2K
  • W. L. Gore & Associates, Inc.$2K
  • Abbott$1K
  • Cook Medical LLC$1K
  • Bolton Medical Inc$650
  • plus $3K from 16 others
$31,092in research payments, 2019–2025

Across 14 payments — averaging $2220.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$15K
  • Zimmer Biomet$12K
  • Vascular Graft Solutions Inc$4K

What the payments were for

  • Speaking & faculty fees$1,3009%
  • Grants$2452%
  • Food & beverage$13,34390%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)46$5,732
Boston Scientific82$1,850
W. L. Gore & Associates, Inc.13$1,602
Abbott12$1,310
Cook Medical LLC10$1,094
Bolton Medical Inc6$650
Penumbra, Inc.3$447
Inari Medical, Inc.3$407
Viz.ai, Inc.2$393
Endologix LLC3$381
Shockwave Medical, Inc1$240
GE HealthCare2$181
Johnson & Johnson2$146
Surmodics, Inc.1$143
Bard Peripheral Vascular, Inc.3$114
Cagent Vascular Inc1$43
Imperative Care, Inc1$34
Cardiovascular Systems Inc.1$30
Limflow Inc.1$30
E.r. Squibb & Sons, L.L.C.1$25
Lemaitre Vascular, Inc.1$25
AstraZeneca1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,888 in reported general payments places this provider in the 70th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York →

Medicare billing

Part B allowed, 2024
$148,014
Medicare patients
171
Services billed
998

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban15$8,401

Paid to pharmacies, not to this prescriber.

Other vascular surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →